Breakthrough: HIV Virus-Killing Condom Developed By Australian Researchers
By Afza Fathima | July 28, 2014 12:42 PM EST
To kill the HIV virus, a new condom has been designed by Australian researchers which could be made available for sale within a few months. Tests on the VivaGel condom has shown that it is effective in deactivating 99.9 per cent of virus cases in HIV, herpes and human papilloma.
Students receive free condoms at an event organised by the United Nations Population Fund (UNFPA) on World Population Day in Manila July 11, 2014.
A receipt of Conformity of Assessment Ceritfication has been received by the product from the Australian Therapeutic Goods Administration. The first of its kind, the condom, should be available for mass production in the coming months.
Lubricated by VivaGel, the condoms contain a non-antibiotic and antimicrobiral drug, astrodrimer sodium, which acts specifically against HIV. The gel, it is hoped, will reduce transmission of sexually transmitted infections, including HIV, and also reduce risk of getting pregnant.
But researchers have warned that there has never been any condom which has been completely effective in preventing pregnancy or spread of STIs. They have said that the VivaGel condoms, to a large extent, will help reduce the chance of an infection by reducing the number of virus particles that a person is exposed to.
Starphama, an Australian bio-tech firm, and Ansell, a firm responsible for a huge portion of the condom market in Australia, are producing the VivaGel condom.
Australia, in the recent years, has seen the rise of sexually transmitted infections. Genital herpes is said to be affecting one in every eight Australians above the age of 25. Many of them are unaware that such an infection has affected them and hence, pass it on to others.
Another shocking statistic is the rise of HIV infections being diagnosed which has increased by a massive 10 per cent in the period between the end of 2012 to the end of 2013. From 1999 to 2013, a huge 70 per cent increase has been noticed in the cases of HIV.
Peter Carroll, President of Ansell, has said that the product should be expected by the consumers soon. He hoped to start the product's marketing and sales campaign in the coming months.
To contact the editor, e-mail:
Most Popular Slideshows
- NFL MNF: Pittsburgh Steelers 30, Houston Texans 23 [PHOTOS]
- 2014 MLB World Series Game 1: San Francisco Giants 7, Kansas City Royals 1 [PHOTOS]
- 2014 MLB World Series - Game 2: Kansas City Royals 7, San Francisco Giants 2 [PHOTOS]
- Prince Harry Kissing Mystery Blond, Cressida Bonas & Camilla Thurlow Are Distant Memory
Join the Conversation
- 12 Terrifyingly Healthy Halloween Treats
- New York Doctor Tests Positive For Ebola
- Kate Middleton Back To Herself After Struggling With Hyperemesis Gravidarum
- Ebola Vaccine: Johnson & Johnson Confident Of Human Trials In January And Market Delivery in May Next Year
- Dead Heart Beats Again, Doctors Use It For Transplant – A World’s First For Australia
- ASUS Releases A Teaser Indicating The Arrival of New Zenfone and ZenWatch On October 28
- Boy Stoned To Death For Alleged Rape, Victim Receives Dowry From Militants
- Xiaomi Redmi 1S vs. Sharp Aquos Crystal – Specifications, Features And Price Showdown
- Three Dual SIM Samsung Galaxy Note 4 Duos Variants Comes To China
- Russia is Creating Underwater Combat Robots to Protect its Arctic Territories
- ‘Lone Wolf’ Attack on Canada Parliament Hill Could be ISIS-Related
- Swedish Military Spots ‘Russian Submarine’ Off Stockholm Coast, An Alarming ‘Security Game Changer’